Jan 22, 2025 8:30 am EST Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
Nov 19, 2024 7:30 am EST Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model
Nov 14, 2024 4:15 pm EST Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability
Nov 04, 2024 7:30 am EST Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement
Oct 31, 2024 7:30 am EDT Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually
Oct 02, 2024 8:00 am EDT Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats
Sep 30, 2024 8:00 am EDT Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities